The present invention relates to the early diagnosis of acute renal failure.
Increases in specific metabolite biomarkers displayed on a heat map provide early diagnosis of these medical conditions to allow for early intervention and aggressive treatment.
The present invention provides an ex vivo method for diagnosis, especially early diagnosis, of proliferative diabetic retinopathy.
The present invention enables the improvement of lesion diagnosis accuracy and early diagnosis rates.
According to the present invention, early diagnosis is possible as bladder cancer can be detected at an early transformation stage, and accurate and rapid diagnosis of bladder cancer is possible as compared to conventional methods.
A compound fingerprint atlas-spectrum model used for early gastric cancer diagnosis/early-warning, and model establishing.
The method permits the early detection and diagnosis of Rickettsia prowazekii exposure and infection and diagnosis of epidemic typhus earlier than any currently available methods.
With a method of the invention, diagnosis during early stages of an infection has become possible.
The management of dengue requires an early and accurate diagnosis.
The present invention permits the early diagnosis of such defects and conditions such as in utero and provides a means for genetic or other therapeutic intervention.
The present invention allows the early diagnosis and molecular diagnosis of glaucoma, and allows the clinician to easily decide whether or not glaucoma is present, in a fashion which is both straightforward and rapid.
A diagnosis kit of the present invention allows an early diagnosis of lung cancer to be performed in a quick and accurate manner compared to conventional methods.
The diagnosis kit of the present invention can be used in the early diagnosis and the monitoring of lung cancer and the progression thereof.
health screening means a procedure using medical radiological installations for early diagnosis in population groups at risk
Measurement of FUBP can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Measurement of RLA-0 can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Measurement of MASP can, e.g., be used in the early detection or diagnosis of colorectal cancer.
Measurement of NNMT can, e.g., be used in the early detection or diagnosis of colorectal cancer.